Canandaigua National Corp’s West Pharmaceutical WST Stock Holding History

Canandaigua National Corp’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$219K	Buy	929 +3	+0.3%	+$711	0.04%	235
2022 Q3	$228K	Sell	926 -2	-0.2%	-$609	0.04%	222
2022 Q2	$281K	Buy	928 +135	+17%	+$43.9K	0.05%	201
2022 Q1	$326K	Sell	793 -1,002	-56%	-$392K	0.05%	211
2021 Q4	$842K	Sell	1,795 -19	-1%	-$8.18K	0.12%	153
2021 Q3	$770K	Buy	1,814 +883	+95%	+$372K	0.13%	154
2021 Q2	$334K	Sell	931 -103	-10%	-$34K	0.05%	205
2021 Q1	$291K	Sell	1,034 -94	-8%	-$26.9K	0.05%	218
2020 Q4	$320K	Sell	1,128 -41	-4%	-$11.5K	0.06%	205
2020 Q3	$321K	Sell	1,169 -138	-11%	-$36.5K	0.06%	196
2020 Q2	$297K	Buy	+1,307	New	+$257K	0.05%	204

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canandaigua National Corp's WST Position: Q4 2022 in Review

Canandaigua National Corp increased its West Pharmaceutical (WST) stake by 0.32% in Q4 2022, buying an estimated $711 and bringing the position to 929 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #235.

Canandaigua National Corp first reported a position in WST in Q2 2020 and has held it in 11 quarters since. The position peaked at $842K in Q4 2021. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

Canandaigua National Corp held 929 shares of West Pharmaceutical worth $219K as of Q4 2022.
Canandaigua National Corp bought 3 West Pharmaceutical shares in Q4 2022, an estimated $711.
West Pharmaceutical made up 0.04% of Canandaigua National Corp's portfolio in Q4 2022, its #235 holding.
Canandaigua National Corp first reported a position in West Pharmaceutical in Q2 2020 and has held it in 11 quarters since.
Canandaigua National Corp's West Pharmaceutical position peaked at $842K in Q4 2021.
637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Canandaigua National Corp's 13F filing for Q4 2022, filed 25 Jan 2023.